Prevention of livedoid vasculopathy recurrence by prolonged administration of rivaroxaban

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):e532. doi: 10.1111/jdv.14404. Epub 2017 Jul 12.

Authors

C Drerup¹, T Goerge¹

Affiliation

¹ Universitaetsklinikum Münster, Muenster, Germany.

PMID: 28609556
DOI: 10.1111/jdv.14404

No abstract available

Publication types

Case Reports

MeSH terms

Drug Administration Schedule
Factor Xa Inhibitors / administration & dosage*
Humans
Livedo Reticularis / drug therapy*
Male
Middle Aged
Rivaroxaban / administration & dosage*

Substances

Factor Xa Inhibitors
Rivaroxaban